Blog | HemaCare

PBMCs and Psoriasis Treatments

Jun 18, 2018 10:11:00 AM / by Stacy Matthews Branch, DVM, PhD posted in B cells, PBMC, PBMCs, peripheral blood mononuclear cells, T helper cells, immune cells

0 Comments

Scientists examined the peripheral blood mononuclear cell (PBMC) profiles of patients with and without psoriasis, including those that both responded to classic treatments and didn’t respond. They then analyzed the profile of those immune cell types. Here are the results of that study.

There are often differences among patient populations for a given disease in how effective a treatment provides medical relief. An important part of personalized medicine is identifying patients that are not likely to respond to a treatment regimen for a specific disease or condition. Doing this can limit the loss of time and resources in using ineffective treatments and can allow the use of personalized treatments in these populations.

Read More

NEW YEAR RESOLUTIONS AND EMERGING ADVANCES IN IMMUNOTHERAPY

Dec 30, 2016 12:00:55 AM / by Stacy Matthews Branch, DVM, PhD posted in B cells, engineered t cells, new immunotherapy advances, T cells, Uncategorized

0 Comments

A new year brings opportunities to reflect and make decisions to produce more success and happiness. These include New Year resolutions about stopping unhealthy habits and replacing with new healthy ones. Whether the goal is to eat more spinach or spend less time playing games on android phones, many will embark on changes aimed to reach health goals. There are new and emerging therapies that can help many who are struggling with medical issues to reach their health goals for the New Year. Developments such as in immunotherapy are changing the way medicine is practiced. It also provides new approaches that help our natural defense mechanisms lead us to healthier states.

Read More

HemaCare's Peripheral Blood Helps Solve a Multiple Sclerosis Riddle

Feb 22, 2016 1:00:04 PM / by Maria posted in B cell depletion therapy, B cells, Multiple Sclerosis, research, T cells, Th17 cells

0 Comments

Depleting B cells improves outcomes for multiple sclerosis patients, but what is the underlying biology? Peripheral blood from HemaCare helped provide answers.

 

Multiple sclerosis is a disease in which the protective myelin coat of nerve cells in the brain and spinal cord become damaged. Consequently, any function related to the central nervous system can be adversely affected, but the most common symptoms are severe fatigue, visual problems, altered sensitivity, and reduced mobility. The root cause of multiple sclerosis is still unknown, but the research community has learned that it is an abnormal immune-mediated response that attacks the myelin coating.

Read More

Using Dendritic Cells to Arm the Immune System via Dying Cancer Cells

Mar 16, 2015 1:00:25 PM / by Daisy posted in B cells, follicular lymphoma, cancer immunotherapy, clinical trial, research, rituximab

0 Comments

Scientists are exploring localized treatment in follicular lymphoma (FL) using dendritic cells that could have long-range benefits on all FL lesions.

Read More

Trichostatin A: A Better Way to Target Chronic Lymphocytic Leukemia Cells?

Oct 27, 2014 1:00:02 PM / by Shweta posted in B cells, apoptosis, Bone marrow, cancer, Cancer Immunology, cell therapy, chemotherapy, chronic lymphocytic leukemia, CLL, disease-state cells, Independent validation, Innovation, PBMCs, Peripheral blood cells, research, white blood cells

0 Comments

Scientists have shown that trichostatin A could be a potent apoptosis inducer to target chronic lymphocytic leukemia cells.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts